Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $37.2600 (-1.11%) ($37.0200 - $38.8700) on Wed. Dec. 2, 2015. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.22% (three month average) | RSI | 67 | Latest Price | $37.2600(-1.11%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 0.3% a day on average for past five trading days. | Weekly Trend | ATRA advances 10.6% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(59%) IBB(53%) ARKG(49%) IWO(48%) ARKK(45%) | Factors Impacting ATRA price | ATRA will decline at least -2.61% in a week (0% probabilities). VIXM(-18%) TLT(-13%) UUP(-8%) UNG(-2%) SHY(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.61% (StdDev 5.22%) | Hourly BBV | 0 () | Intraday Trend | -2.3% | | | |
|
5 Day Moving Average | $38.45(-3.09%) | 10 Day Moving Average | $36.33(2.56%) | 20 Day Moving Average | $34.41(8.28%) | To recent high | -5.8% | To recent low | 56% | Market Cap | $2.769b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |